Kreon

Pancrelipase, the active ingredient in Kreon, is a digestive enzyme presented as a capsule for oral use. It provides lipase, amylase and protease to aid digestion of fats, proteins and carbohydrates in patients with exocrine pancreatic insufficiency caused by cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after pancreatic resection.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with distribution across EU and other regulated markets, and adhering to stringent quality standards.

Kreon is used to manage exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. - Cystic fibrosis: improves digestion and nutrient absorption by supplementing deficient pancreatic enzymes. - Chronic pancreatitis: reduces steatorrhea and malabsorption symptoms through enzyme replacement. - Pancreatic cancer: aids digestion when tumor or treatment impairs pancreatic function. - Post‑pancreatic resection: supports nutrient assimilation after surgical removal of pancreatic tissue.

Kreon may cause adverse reactions related to its enzyme content and capsule excipients.

Common Side Effects: - Abdominal discomfort: mild pain or cramping after dosing. - Diarrhea: increased loose stools. - Nausea: feeling of sickness. - Flatulence: excess gas production. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis. - Fibrosing colonopathy: rare intestinal scarring. - Pancreatitis exacerbation: worsening pancreatic inflammation. - Severe abdominal pain: persistent or worsening pain. - Respiratory distress: difficulty breathing.

When prescribing Kreon, clinicians should consider several safety and handling precautions. - Assess pancreatic function: confirm exocrine insufficiency before initiating therapy. - Monitor nutritional status: regularly evaluate weight, vitamin levels and stool fat content. - Adjust dose with diet: titrate based on fat intake and clinical response. - Watch for hypersensitivity: discontinue if signs of allergic reaction appear. - Avoid concomitant antacids: may reduce enzyme activity if taken simultaneously. - Store at ambient temperature: keep capsules below 25°C in the original container, protected from moisture.

Kreon can interact with certain medicines, affecting enzyme activity or absorption.

Major Interactions (Avoid): - Proton pump inhibitors: reduce gastric acidity, potentially decreasing enzyme activation. - H2‑receptor antagonists: may lower enzyme efficacy by raising gastric pH. - Antacids containing aluminum or magnesium: can bind enzymes and impair their function.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: may increase risk of gastrointestinal irritation. - Warfarin: rare reports of altered INR, monitor coagulation parameters. - Lipid‑lowering agents (e.g., orlistat): may interfere with fat digestion and affect enzyme performance.